ARTICLE | Clinical News
Cycloset regulatory update
May 11, 2009 7:00 AM UTC
FDA approved an NDA from VeroScience for Cycloset bromocriptine timed-release tablets to treat Type II diabetes. S2 Therapeutics Inc. (Bristol, Tenn.) has worldwide marketing rights to the drug. VeroS...